Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360536 · ClinicalTrials.gov registry record · NA
Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women
A NA study of Overweight or Obesity and Resistance Training, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06360536: Recruiting NA study of Overweight or Obesity and Resistance Training, sponsored by University of Alabama at Birmingham.
NCT06360536 is a NA study of Overweight or Obesity and Resistance Training that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 36 participants, below the 31,711-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06360536, a NA study of Overweight or Obesity and Resistance Training, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.
Primary Outcome
The number of participants enrolled in the trial
Conditions Studied
Interventions
- BEHAVIORAL Resistance Training
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-06-04 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06360536 shows while recruiting
NCT06360536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 31,711-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Overweight or Obesity appearing as the primary indexed condition, and to 1 intervention - of which Resistance Training is the first listed.
NCT06360536 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06360536 about?
NCT06360536 is a clinical study titled "Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women". The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.
What is the current status of trial NCT06360536?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-06-04. Estimated completion is 2026-06-30.
What conditions does trial NCT06360536 study?
This clinical trial studies the following conditions: Overweight or Obesity, Resistance Training, Prediabetes or Diabetes, Prehypertension (Elevated Blood Pressure) or Hypertension.
What interventions are being tested in trial NCT06360536?
The interventions under investigation include: Resistance Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06360536?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06360536 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight or Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06360536's enrollment target sits among peer trials
36 28th of 32 higher than 5 of 32 other Overweight or Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight or Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
RECRUITING · NA
-
Craving Network Neurofeedback
RECRUITING · NA
-
Postprandial Effects of Animal Versus Plant-Based Protein
RECRUITING · NA
-
eMOTION: Examining Affective Mechanisms in Physical Activity Engagement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI